 Cytokine Receptor gp130
"Cytokine Receptor gp130" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cytokine receptor that acts through the formation of oligomeric complexes of itself with a variety of CYTOKINE RECEPTORS.
| Descriptor ID |
D050822
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.400.500 D12.776.543.750.705.852.420.560.249 D12.776.543.750.705.852.500.500 D12.776.543.750.705.852.555.600.500 D12.776.543.750.705.852.555.800.500 D12.776.543.750.750.400.550.250.500 D23.050.301.264.035.280 D23.101.100.110.280
|
| Concept/Terms |
Cytokine Receptor gp130- Cytokine Receptor gp130
- Receptor gp130, Cytokine
- gp130, Cytokine Receptor
- CD130 Antigens
- gp130 IL-6 Family Receptor
- gp130 IL 6 Family Receptor
- gp130 Signal Transducer
- Signal Transducer, gp130
- Signal-Transducing Receptor gp130
- Receptor gp130, Signal-Transducing
- Signal Transducing Receptor gp130
- gp130, Signal-Transducing Receptor
- IL-6 Family Receptor gp130
- IL-6 Receptor Signal Transducer gp130
- IL6ST gp130
- Signal Transducer gp130
- gp130, Signal Transducer
- Antigens, CD130
- gp130 Transducing Protein
|
Below are MeSH descriptors whose meaning is more general than "Cytokine Receptor gp130".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Interleukin [D12.776.543.750.705.852.420]
- Receptors, Interleukin-6 [D12.776.543.750.705.852.420.400]
- Cytokine Receptor gp130 [D12.776.543.750.705.852.420.400.500]
- Receptors, Interleukin-11 [D12.776.543.750.705.852.420.560]
- Cytokine Receptor gp130 [D12.776.543.750.705.852.420.560.249]
- Receptors, OSM-LIF [D12.776.543.750.705.852.500]
- Cytokine Receptor gp130 [D12.776.543.750.705.852.500.500]
- Receptors, Oncostatin M [D12.776.543.750.705.852.555]
- Receptors, Oncostatin M, Type II [D12.776.543.750.705.852.555.600]
- Cytokine Receptor gp130 [D12.776.543.750.705.852.555.600.500]
- Receptors, OSM-LIF [D12.776.543.750.705.852.555.800]
- Cytokine Receptor gp130 [D12.776.543.750.705.852.555.800.500]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Growth Factor [D12.776.543.750.750.400]
- Receptors, Nerve Growth Factor [D12.776.543.750.750.400.550]
- Receptor, Ciliary Neurotrophic Factor [D12.776.543.750.750.400.550.250]
- Cytokine Receptor gp130 [D12.776.543.750.750.400.550.250.500]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, CD [D23.050.301.264.035]
- Cytokine Receptor gp130 [D23.050.301.264.035.280]
- Biological Markers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, CD [D23.101.100.110]
- Cytokine Receptor gp130 [D23.101.100.110.280]
Below are MeSH descriptors whose meaning is more specific than "Cytokine Receptor gp130".
This graph shows the total number of publications written about "Cytokine Receptor gp130" by people in this website by year, and whether "Cytokine Receptor gp130" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 | | 2010 | 1 | 0 | 1 | | 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cytokine Receptor gp130" by people in Profiles.
-
Tiwari P, Blank A, Cui C, Schoenfelt KQ, Zhou G, Xu Y, Khramtsova G, Olopade F, Shah AM, Khan SA, Rosner MR, Becker L. Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer. J Exp Med. 2019 06 03; 216(6):1345-1358.
-
Malchow S, Thaiss W, Jänner N, Waetzig GH, Gewiese-Rabsch J, Garbers C, Yamamoto K, Rose-John S, Scheller J. Essential role of neutrophil mobilization in concanavalin A-induced hepatitis is based on classic IL-6 signaling but not on IL-6 trans-signaling. Biochim Biophys Acta. 2011 Mar; 1812(3):290-301.
-
Stumhofer JS, Tait ED, Quinn WJ, Hosken N, Spudy B, Goenka R, Fielding CA, O'Hara AC, Chen Y, Jones ML, Saris CJ, Rose-John S, Cua DJ, Jones SA, Elloso MM, Grötzinger J, Cancro MP, Levin SD, Hunter CA. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat Immunol. 2010 Dec; 11(12):1119-26.
-
Gewiese-Rabsch J, Drucker C, Malchow S, Scheller J, Rose-John S. Role of IL-6 trans-signaling in CCl4induced liver damage. Biochim Biophys Acta. 2010 Nov; 1802(11):1054-61.
-
Drucker C, Gewiese J, Malchow S, Scheller J, Rose-John S. Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration. J Autoimmun. 2010 Feb; 34(1):29-37.
-
Ezure T, Sakamoto T, Tsuji H, Lunz JG, Murase N, Fung JJ, Demetris AJ. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol. 2000 May; 156(5):1627-39.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|